




Instance: composition-en-0038e5833697485dc38d33d1305d9883
InstanceOf: CompositionUvEpi
Title: "Composition for clopidogrelacetylsalicylic Package Leaflet"
Description:  "Composition for clopidogrelacetylsalicylic Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp4508a59f31e3d5810d220a288641c8f2)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - clopidogrelacetylsalicylic"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Clopidogrel/Acetylsalicylic acid Zentiva is and what it is used for </li>
<li>What you need to know before you take Clopidogrel/Acetylsalicylic acid Zentiva </li>
<li>How to take Clopidogrel/Acetylsalicylic acid Zentiva </li>
<li>Possible side effects </li>
<li>How to store Clopidogrel/Acetylsalicylic acid Zentiva </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What clopidogrelacetylsalicylic is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What clopidogrelacetylsalicylic is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Clopidogrel/Acetylsalicylic acid Zentiva contains clopidogrel and acetylsalicylic acid (ASA) and 
belongs to a group of medicines called antiplatelet medicinal products. Platelets are very small 
structures in the blood which clump together during blood clotting. By preventing this clumping in 
some types of blood vessels (called arteries), antiplatelet medicinal products reduce the chances of 
blood clots forming (a process called atherothrombosis). </p>
<p>Clopidogrel/Acetylsalicylic acid Zentiva is taken by adults to prevent blood clots forming in hardened 
arteries which can lead to atherothrombotic events (such as stroke, heart attack, or death).  </p>
<p>You have been prescribed Clopidogrel/Acetylsalicylic acid Zentiva in place of the two separate 
medicines, clopidogrel and ASA, to help prevent blood clots because you have experienced a severe 
type of chest pain known as  unstable angina  or heart attack (myocardial infarction). For the treatment 
of this condition your doctor may have placed a stent in the blocked or narrowed artery to restore 
effective blood flow. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take clopidogrelacetylsalicylic"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take clopidogrelacetylsalicylic"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Clopidogrel/Acetylsalicylic acid Zentiva  </p>
<p>if you are allergic to clopidogrel, acetylsalicylic acid (ASA) or any of the other ingredients of 
this medicine (listed in section 6).  </p>
<p>if you are allergic to other products called non-steroidal anti-inflammatory products usually used 
to treat painful and/or inflammatory conditions of muscles or joints. </p>
<p>if you have a medical condition that includes the combination of asthma, nasal discharge (runny 
nose) and polyps (a type of growth in the nose). </p>
<p>if you have a medical condition that is currently causing bleeding such as a stomach ulcer or 
bleeding within the brain. </p>
<p>if you suffer from severe liver disease. </p>
<p>if you suffer from severe kidney disease. </p>
<p>if you are in your last trimester of pregnancy.  </p>
<p>Warnings and precautions </p>
<p>If any of the situations mentioned below apply to you, you should tell your doctor before taking 
Clopidogrel/Acetylsalicylic acid Zentiva: </p>
<p>if you have a risk of bleeding such as:</p>
<ul>
<li>a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer). </li>
<li>a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, 
organs or joints of your body). </li>
<li>a recent serious injury. </li>
<li>a recent surgery (including dental). </li>
<li>a planned surgery (including dental) in the next seven days. </li>
</ul>
<p>if you have had a clot in an artery of your brain (ischaemic stroke) which occurred in the last 
seven days. </p>
<p>if you have kidney or liver disease. </p>
<p>if you have a history of asthma or allergic reactions including allergy to any medicine used to 
treat your disease.  </p>
<p>if you have gout.  </p>
<p>if you drink alcohol, because of the increased risk of bleeding or gastrointestinal injury. </p>
<p>if you have a condition known as glucose-6-phosphate dehydrogenase (G6PD) deficiency 
because of the risk of a particular form of anaemia (low number of red blood cells). </p>
<p>While you are taking Clopidogrel/Acetylsalicylic acid Zentiva: </p>
<p>You should tell your doctor 
- if a surgery (including dental) is planned. 
- if you have any stomach or abdominal pain or bleeding in the stomach or bowels (red 
stools or black stools). </p>
<p>You should also tell your doctor immediately if you develop a medical condition known as 
Thrombotic Thrombocytopenic Purpura or TTP that includes fever and bruising under the skin 
that may appear as red pinpoint dots, with or without unexplained extreme tiredness, confusion, 
yellowing of the skin or eyes (jaundice) (see section 4). </p>
<p>If you cut or injure yourself, it may take longer than usual for bleeding to stop. This is linked to 
the way your medicine works as it prevents the ability of blood clots to form. For minor cuts and 
injuries e.g., cutting yourself, shaving, this is usually of no concern. However, if you are 
concerned by your bleeding, you should contact your doctor straightaway (see section 4. Possible side effects ). </p>
<p>Your doctor may order blood tests. </p>
<p>Children and adolescents 
Clopidogrel/Acetylsalicylic acid Zentiva is not intended for use in children or adolescents less than 
18 years of age. There is a possible association between acetylsalicylic acid (ASA) and Reye s 
Syndrome when products containing ASA are given to children or adolescents with a viral infection. 
Reye s Syndrome is a very rare disease which can be fatal. </p>
<p>Other medicines and Clopidogrel/Acetylsalicylic acid Zentiva 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. 
Some other medicines may influence the use of Clopidogrel/Acetylsalicylic acid Zentiva or vice versa. </p>
<p>You should specifically tell your doctor if you take </p>
<p>medicines that may increase your risk of bleeding such as:</p>
<ul>
<li>oral anticoagulants, medicines used to reduce blood clotting,  </li>
<li>ASA or another non-steroidal anti-inflammatory medicine usually used to treat painful 
and/or inflammatory conditions of muscle or joints, </li>
<li>
<p>heparin or any other injectable medicine used to reduce blood clotting, </p>
</li>
<li>
<p>ticlopidine, other antiplatelet agent, </p>
</li>
<li>a selective serotonin reuptake inhibitor (including but not restricted to fluoxetine or 
fluvoxamine), medicines usually used to treat depression, </li>
</ul>
<p>omeprazole or esomeprazole, medicines to treat upset stomach, </p>
<p>methotrexate, a medicine used to treat severe joint disease (rheumatoid arthritis) or skin disease 
(psoriasis),  </p>
<p>acetazolamide, a medicine used to treat glaucoma (increased ocular pressure) or epilepsy or to 
increase urine flow, </p>
<p>probenecid, benzbromarone, or sulfinpyrazone, medicines used to treat gout, </p>
<p>fluconazole or voriconazole, medicines to treat fungal infections,  </p>
<p>efavirenz or tenofovir, medicines to treat HIV (human immunodeficiency virus) infections, </p>
<p>valproic acid, valproate or carbamazepine, medicines to treat some forms of epilepsy, </p>
<p>the varicella vaccine, a medicine used to prevent chickenpox or shingles, within 6 weeks of 
taking Clopidogrel/Acetylsalicylic acid Zentiva, or if you have active chickenpox or shingles 
infection (see section 2  Children and adolescents ), </p>
<p>moclobemide, medicine to treat depression, </p>
<p>repaglinide, medicine to treat diabetes,  </p>
<p>paclitaxel, medicine to treat cancer, </p>
<p>nicorandil, medicine to treat cardiac chest pain, </p>
<p>opioids: while you are treated with clopidogrel, you should inform your doctor before being 
prescribed any opioids treatment. </p>
<p>You should stop other clopidogrel treatment while you are taking Clopidogrel/Acetylsalicylic acid 
Zentiva. </p>
<p>An occasional use of ASA (no more than 1,000 mg in any 24-hour period) should generally not cause 
a problem, but prolonged use of ASA in other circumstances should be discussed with your doctor or 
pharmacist. </p>
<p>Pregnancy and breast-feeding 
Do not take Clopidogrel/Acetylsalicylic acid Zentiva during third trimester of pregnancy. 
It is preferable not to take this medicine during first and second trimesters of pregnancy. </p>
<p>If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist 
before taking Clopidogrel/Acetylsalicylic acid Zentiva. If you become pregnant while taking 
Clopidogrel/Acetylsalicylic acid Zentiva, consult your doctor immediately as it is recommended not to 
take Clopidogrel/Acetylsalicylic acid Zentiva while you are pregnant.  </p>
<p>You should not breast-feed while using this medicine. 
If you are breast-feeding or planning to breast-feed, talk to your doctor before taking this medicine. </p>
<p>Ask your doctor or pharmacist for advice before taking any medicine. </p>
<p>Driving and using machines 
Clopidogrel/Acetylsalicylic acid Zentiva should not affect your ability to drive or to use machines. </p>
<p>Clopidogrel/Acetylsalicylic acid Zentiva contains lactose<br />
If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact 
your doctor before taking this medicine.  </p>
<p>Clopidogrel/Acetylsalicylic acid Zentiva contains hydrogenated castor oil<br />
This may cause stomach upset or diarrhoea.  </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take clopidogrelacetylsalicylic"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take clopidogrelacetylsalicylic"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>The recommended dose is one tablet of Clopidogrel/Acetylsalicylic acid Zentiva per day to be taken 
orally with a glass of water, with or without food. </p>
<p>You should take your medicine at the same time each day. </p>
<p>Depending on your condition, your doctor will determine the length of time for which you need to take 
Clopidogrel/Acetylsalicylic acid Zentiva. If you have had a heart attack, it should be prescribed for at 
least four weeks. In any case, you should take it for as long as your doctor continues to prescribe it.  </p>
<p>If you take more Clopidogrel/Acetylsalicylic acid Zentiva than you should 
Contact your doctor or the nearest hospital emergency department because of the increased risk of 
bleeding. </p>
<p>If you forget to take Clopidogrel/Acetylsalicylic acid Zentiva 
If you forget to take a dose of Clopidogrel/Acetylsalicylic acid Zentiva, but remember within 12 hours 
of your usual time, take your tablet straightaway and then take your next tablet at the usual time.  </p>
<p>If you forget for more than 12 hours, simply take the next single dose at the usual time. Do not take a 
double dose to make up for a forgotten tablet.  </p>
<p>For the 14, 28 and 84 tablets pack sizes you can check the day on which you last took a tablet of 
Clopidogrel/Acetylsalicylic acid Zentiva by referring to the calendar printed on the blister. </p>
<p>If you stop taking Clopidogrel/Acetylsalicylic acid Zentiva 
Do not stop the treatment unless your doctor tells you so. Contact your doctor before stopping or 
restarting your treatment. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.  </p>
<p>Contact your doctor immediately if you experience: </p>
<p>fever, signs of infection or extreme tiredness. These may be due to rare decrease of some blood 
cells.  </p>
<p>signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not 
associated with bleeding which appears under the skin as red pinpoint dots, and/or confusion 
(see section 2  Warnings and precautions ). </p>
<p>swelling in the mouth or skin disorders such as rashes and itching, blisters of the skin. These 
may be the signs of an allergic reaction. </p>
<p>The most common side effect which has been seen with Clopidogrel/Acetylsalicylic acid Zentiva 
is bleeding. Bleeding may occur as bleeding in the stomach or bowels, bruising, haematoma (unusual 
bleeding or bruising under the skin), nose bleed, blood in the urine. In a small number of cases, 
bleeding in the eye, inside the head (especially in elderly), the lung or the joints has also been 
reported. </p>
<p>If you experience prolonged bleeding when taking Clopidogrel/Acetylsalicylic acid Zentiva 
If you cut or injure yourself, it may take longer than usual for bleeding to stop. This is linked to the 
way your medicine works as it prevents the ability of blood clots to form. For minor cuts and injuries </p>
<p>e.g., cutting yourself, shaving, this is usually of no concern. However, if you are concerned by your 
bleeding, you should contact your doctor straightaway (see section 2  Warnings and precautions ). </p>
<p>Other side effects include: 
Common side effects (may affect up to 1 in 10 people):<br />
Diarrhoea, abdominal pain, indigestion or heartburn. </p>
<p>Uncommon side effects (may affect up to 1 in 100 people):<br />
Headache, stomach ulcer, vomiting, nausea, constipation, excessive gas in stomach or intestines, 
rashes, itching, dizziness, sensation of tingling and numbness. </p>
<p>Rare side effect (may affect up to 1 in 1000 people):<br />
Vertigo, enlarged breasts in males. </p>
<p>Very rare side effects (may affect up to 1 in 10,000 people):<br />
Jaundice (yellowing of skin and/or eyes); burning in stomach and/or esophagus (gullet); severe 
abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with 
cough; generalised allergic reactions (for example, overall sensation of heat with sudden general 
discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth 
(stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes 
in taste or loss of taste of foods, inflammation of small vessels.  </p>
<p>Side effects with frequency not known (frequency cannot be estimated from the available data):<br />
Ulcer perforation, ringing in the ears, hearing loss, sudden life-threatening allergic or hypersensitivity 
reactions with chest or abdominal pain, kidney disease, low blood sugar, gout (a condition of painful, 
swollen joints caused by uric acid crystals) and worsening of food allergies, a particular form of 
anaemia (low number of red blood cells) (see section 2  Warnings and precautions ), swelling. </p>
<p>In addition, your doctor may identify changes in your blood or urine tests. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store clopidogrelacetylsalicylic"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store clopidogrelacetylsalicylic"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children.  </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and on the blister, after 
EXP. The expiry date refers to the last day of that month. </p>
<p>Store below 25 C. </p>
<p>Do not use this medicine if you notice any visible sign of deterioration. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help to protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Clopidogrel/Acetylsalicylic acid Zentiva contains </p>
<p>Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/75 mg film-coated tablets </p>
<p>The active substances are clopidogrel and acetylsalicylic acid (ASA). Each tablet contains 75 mg of 
clopidogrel (as hydrogen sulphate) and 75 mg of acetylsalicylic acid. </p>
<p>The other ingredients are:</p>
<ul>
<li>Tablet core: mannitol (E421), macrogol 6000, microcrystalline cellulose, low substituted 
hydroxypropylcellulose, maize starch, hydrogenated castor oil (see section 2 
 Clopidogrel/Acetylsalicylic acid Zentiva contains hydrogenated castor oil ), stearic acid and 
colloidal anhydrous silica </li>
<li>Tablet coating: lactose monohydrate (see section 2  Clopidogrel/Acetylsalicylic acid Zentiva 
contains lactose ), hypromellose (E464), titanium dioxide (E171), triacetin (E1518), yellow iron 
oxide (E172) </li>
<li>Polishing agent: carnauba wax </li>
</ul>
<p>Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/100 mg film-coated tablets 
The active substances are clopidogrel and acetylsalicylic acid (ASA). Each tablet contains 75 mg of 
clopidogrel (as hydrogen sulphate) and 100 mg of acetylsalicylic acid. </p>
<p>The other ingredients are:</p>
<ul>
<li>Tablet core: mannitol (E421), macrogol 6000, microcrystalline cellulose, low substituted 
hydroxypropylcellulose, maize starch, hydrogenated castor oil (see section 2 
 Clopidogrel/Acetylsalicylic acid Zentiva contains hydrogenated castor oil ), stearic acid and 
colloidal anhydrous silica </li>
<li>Tablet coating: lactose monohydrate (see section 2  Clopidogrel/Acetylsalicylic acid Zentiva 
contains lactose ), hypromellose (E464), titanium dioxide (E171), triacetin (E1518), red iron 
oxide (E172) </li>
<li>Polishing agent: carnauba wax </li>
</ul>
<p>What Clopidogrel/Acetylsalicylic acid Zentiva looks like and contents of the pack </p>
<p>Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/75 mg film-coated tablets 
Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/75 mg film-coated tablets (tablets) are oval, slightly 
biconvex, yellow, engraved on one side with  C75  and  A75 on the other side. 
Clopidogrel/Acetylsalicylic acid Zentiva is supplied in cardboard cartons containing:</p>
<ul>
<li>14, 28, 30 and 84 tablets in all-aluminium blisters </li>
<li>30x1, 50x1, 90x1 and 100x1 tablet in all-aluminium perforated unit-dose blisters. </li>
</ul>
<p>Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/100 mg film-coated tablets 
Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/100 mg film-coated tablets (tablets) are oval, slightly 
biconvex, light pink, engraved on one side with  C75  and  A100 on the other side. 
Clopidogrel/Acetylsalicylic acid Zentiva is supplied in cardboard cartons containing:</p>
<ul>
<li>14, 28 and 84 tablets in all-aluminium blisters </li>
<li>30x1, 50x1, 90x1 and 100x1 tablet in all-aluminium perforated unit-dose blisters. </li>
</ul>
<p>Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer </p>
<p>Marketing Authorisation Holder:<br />
sanofi-aventis groupe 
54, rue La Bo tie 
F-75008 Paris 
France </p>
<p>Manufacturer: 
Sanofi Winthrop Industrie 
1, rue de la Vierge, Ambar s &amp; Lagrave, F-33565 Carbon Blanc cedex, France </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder:  </p>
<p>Belgi /Belgique/Belgien 
Sanofi Belgium 
T l/Tel: +32 (0)2 710 54 Lietuva 
UAB  SANOFI-AVENTIS LIETUVA<br />
Tel: +370 5 2755<br />
SANOFI BULGARIA EOOD 
 : +359 (0)2 970 53 Luxembourg/Luxemburg 
Sanofi Belgium<br />
T l/Tel: +32 (0)2 710 54 00 (Belgique/Belgien) </p>
<p>esk  republika 
sanofi-aventis, s.r.o. 
Tel: +420 233 086 Magyarorsz g 
SANOFI-AVENTIS Zrt.<br />
Tel.: +36 1 505 0Danmark 
Sanofi A/S 
Tlf: +45 45 16 70 Malta 
Sanofi Malta Ltd. 
Tel: +356 21493Deutschland 
Zentiva Pharma GmbH 
Tel.: +49 (0)180 20 200 Nederland 
sanofi-aventis Netherlands B.V. 
Tel: +31 20 245 4Eesti 
sanofi-aventis Estonia O<br />
Tel: +372 627 3Norge 
sanofi-aventis Norge AS 
Tlf: +47 67 10 71 <br />
sanofi-aventis AEBE 
 : +30 210 900 16  sterreich 
sanofi-aventis GmbH 
Tel: +43 1 80 185   0 </p>
<p>Espa a 
sanofi-aventis, S.A. 
Tel: +34 93 485 94 Polska 
sanofi-aventis Sp. z o.o. 
Tel: +48 22 280 00 France 
sanofi-aventis France 
T l: 0 800 222 Appel depuis l tranger: +33 1 57 63 23 Portugal 
Sanofi - Produtos Farmac uticos, Lda 
Tel: +351 21 35 89 Hrvatska 
sanofi-aventis Croatia d.o.o. 
Tel: +385 1 600 34 Rom nia 
Sanofi Romania SRL 
Tel: +40 (0) 21 317 31 Ireland 
sanofi-aventis Ireland Ltd. T/A SANOFI 
Tel: +353 (0) 1 403 56 Slovenija 
sanofi-aventis d.o.o. 
Tel: +386 1 560 48  sland 
Vistor hf. 
S mi: +354 535 7Slovensk  republika 
sanofi-aventis Pharma Slovakia s.r.o. 
Tel: +421 2 33 100 Italia 
Zentiva Italia S.r.l. 
Tel: 800.536 Suomi/Finland 
Sanofi Oy 
Puh/Tel: +358 (0) 201 200 <br />
sanofi-aventis Cyprus Ltd. 
 : +357 22 871Sverige 
Sanofi AB 
Tel: +46 (0)8 634 50 Latvija 
sanofi-aventis Latvia SIA 
Tel: +371 67 33 24 United Kingdom 
Sanofi 
Tel: +44 (0) 845 372 7This leaflet was last revised in <em>Month YYYY</em>. </p>
<p>Detailed information on this medicine is available on the European Medicines Agency website: 
http://www.ema.europa.eu/  </p>         </div>"""      



Instance: composition-da-0038e5833697485dc38d33d1305d9883
InstanceOf: CompositionUvEpi
Title: "Composition for clopidogrelacetylsalicylic Package Leaflet"
Description:  "Composition for clopidogrelacetylsalicylic Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp4508a59f31e3d5810d220a288641c8f2)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - clopidogrelacetylsalicylic"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal du vide, før du begynder at tage Clopidogrel/Acetylsalicylsyre Zentiva 
3. Sådan skal du tage Clopidogrel/Acetylsalicylsyre Zentiva 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What clopidogrelacetylsalicylic is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What clopidogrelacetylsalicylic is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Clopidogrel/Acetylsalicylsyre Zentiva indeholder clopidogrel og acetylsalicylsyre (ASA) og tilhører 
en gruppe medicin, der kaldes blodfortyndende medicin. Blodplader er meget små bestanddele i 
blodet, som klumper sig sammen, når blodet størkner. Ved at forhindre denne sammenklumpning i 
visse typer blodkar (kaldet arterier) nedsætter et blodfortyndende præparat risikoen for, at der dannes 
blodpropper (en proces, der kaldes aterotrombose). </p>
<p>Clopidogrel/Acetylsalicylsyre Zentiva tages af voksne for at forebygge dannelse af blodpropper i 
blodårer, som er blevet stive. Blodpropper kan føre til f.eks. slagtilfælde, hjerteanfald og død 
(aterotrombotiske hændelser).  </p>
<p>Du har fået ordineret Clopidogrel/Acetylsalicylsyre Zentiva i stedet for de to indholdsstoffer 
clopidogrel og acetylsalicylsyre enkeltvist for at forebygge blodpropper, fordi du har haft en alvorlig 
form for smerter i brystet (ustabil angina pectoris) eller et hjerteanfald (myokardieinfarkt). For at 
behandle denne tilstand kan lægen have indopereret en stent (rør) i den blokerede eller forsnævrede 
blodåre (arterie) for at genoprette en effektiv blodgennemstrømning.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take clopidogrelacetylsalicylic"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take clopidogrelacetylsalicylic"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Clopidogrel/Acetylsalicylsyre Zentiva: 
 
hvis du er allergisk over for clopidogrel, acetylsalicylsyre eller et af de øvrige indholdsstoffer i 
dette lægemiddel (angivet i afsnit 6). 
 
hvis du er overfølsom over for medicin, der kaldes non-steroide antiinflammatoriske stoffer 
(NSAID’er), der sædvanligvis anvendes til behandling af smertefulde og/eller 
betændelseslignende tilstande i muskler eller led (gigt). 
 
hvis du har en sygdom, der omfatter konbinationen af astma, løbenæse og polypper (en udvækst 
i næsen). </p>
<p> 
hvis du har aktiv blødning såsom et mavesår eller blødning i hjernen. 
 
hvis du lider af en alvorlig nyresygdom. 
 
hvis du lider af en alvorlig leversygdom. 
 
hvis du er gravid i tredje trimester. </p>
<p>Advarsler og forsigtighedsregler 
Hvis nogen af følgende situationer gælder for dig, skal du oplyse det til lægen, før du tager 
Clopidogrel/Acetylsalicylsyre Zentiva: 
 
hvis du har risiko for blødninger f.eks. på grund af:</p>
<ul>
<li>en sygdom, der medfører risiko for indre blødninger (såsom et mavesår). </li>
<li>en blødningsforstyrrelse, der giver tendens til indre blødninger (blødning inde i et af 
kroppens væv, organer eller led). </li>
<li>en nylig alvorlig kvæstelse. </li>
<li>et nyligt kirurgisk indgreb (gælder også tandoperationer). </li>
<li>et planlagt kirurgisk indgreb (gælder også tandoperationer) inden for de næste 7 dage. 
 
hvis du har haft en blodprop i en åre (arterie) i hjernen (iskæmisk slagtilfælde) inden for de 
seneste 7 dage. 
 
hvis du lider af en nyre- eller leversygdom. 
 
hvis du har haft tidligere tilfælde af astma eller allergiske reaktioner inklusive allergi mod et 
lægemiddel, der anvendes til at behandle din sygdom. 
 
hvis du lider af urinsur gigt. 
 
hvis du drikker alkohol, da der er en øget risiko for blødning i eller skader på mave-tarm 
kanalen 
 
hvis du har en lidelse, der kaldes glucose-6-phosphatdehydrogenase(G6PD)-mangel, da G6PD-
mangel øger risikoen for en særlig form for anæmi (lavt antal røde blodceller). </li>
</ul>
<p>Mens du er i behandling med Clopidogrel/Acetylsalicylsyre Zentiva: 
 
skal du fortælle lægen, at du er i behandling med Clopidogrel/Acetylsalicylsyre Zentiva: 
 
hvis du skal have foretaget en planlagt operation (også hos tandlægen). 
 
hvis du får smerter i maveregionen eller blødning i mave eller tarme (rød eller sort 
afføring). 
 
skal du også straks kontakte din læge, hvis du udvikler en tilstand kendt som trombotisk 
trombocytopenisk purpura eller TTP, der giver feber og små blødninger under huden (det kan 
vise sig som små, røde prikker) med eller uden uforklarlig ekstrem træthed, forvirring, 
gulfarvning af huden eller øjnene (gulsot) (se afsnit 4). 
 
kan det tage lidt længere end normalt, før blødningen stopper, hvis du skærer dig eller kommer 
til skade. Dette skyldes medicinens virkemåde, da den forhindrer blodet i at størkne. Ved 
mindre sår og skader, som hvis du f.eks. skærer dig under barbering, er dette som regel ikke 
noget problem. Hvis du er bekymret over blødningen, skal du omgående kontakte din læge (se 
afsnit 4 ’Bivirkninger’). 
 
kan din læge bede om at få taget blodprøver. </p>
<p>Børn og unge 
Clopidogrel/Acetylsalicylsyre Zentiva er ikke tiltænkt anvendelse hos børn og unge under 18 år. Der 
er en mulig sammenhæng mellem acetylsalicylsyre og Reyes syndrom, når lægemidler, der indeholder 
acetylsalicylsyre, gives til børn og unge med en virusinfektion. Reyes syndrom er en meget sjælden 
sygdom, der kan være livstruende.  </p>
<p>Brug af anden medicin sammen med Clopidogrel/Acetylsalicylsyre Zentiva 
Fortæl det altid til lægen eller apotekspersonalet, hvis du tager anden medicin eller har gjort det for 
nyligt.<br />
Visse andre typer medicin kan påvirke virkningen af Clopidogrel/Acetylsalicylsyre Zentiva eller 
omvendt. </p>
<p>Du skal fortælle lægen, hvis du tager 
 
medicin, der kan øge risikoen for blødning såsom: </p>
<ul>
<li>medicin, som modvirker blodets størkning (blodfortyndende medicin, orale 
antikoagulantia) gennem munden. * 
acetylsalicylsyre eller andre non-steroide antiinflammatoriske stoffer (NSAID’er), der 
sædvanligvis anvendes til behandling af smertefulde og/eller betændelseslignende tilstande 
i muskler eller led (gigt). * 
heparin eller anden medicin til indsprøjtning til at nedsætte dannelse af blodpropper. * 
ticlopidin, der er anden medicin mod blodpropper  * 
selektive serotoningenoptagelseshæmmere (inklusive, men ikke begrænset til fluoxetin og 
fluvoxamin), der normalt anvendes mod depression 
 
omeprazol eller esomeprazol til behandling af for meget mavesyre. 
 
methotrexat, et lægemiddel der anvendes til at behandle alvorlige ledsygdomme (reumatoid artrit) 
eller hudsygdomme (psoriasis).<br />
 
acetazolamid, et lægemiddel der anvendes til at behandle glaukom (forhøjet tryk i øjet) eller 
epilepsi eller til at øge urinflow. 
 
probenecid, benzbromaron eller sulfipyrazon, lægemidler til behandling af urinsur gigt. 
 
fluconazol eller voriconazol, der anvendes til behandling af svampeinfektioner.<br />
 
efavirenz eller tenofovir, medicin der anvendes til behandling af HIV- (humant immundefektvirus) 
infektion 
 
valproinsyre, valproat eller carbamazepin, medicin til behandling af bestemte typer epilepsi. 
 
bliver vaccineret mod skoldkopper eller helvedesild indenfor 6 uger efter brug af 
Clopidogrel/Acetylsalicylsyre Zentiva, eller hvis du har/får skoldkopper eller helvedsild (se afsnit 
2 ”Børn og unge”) 
 
moclobemid, medicin mod depression. 
 
repaglinid, medicin til behandling af sukkersyge (diabetes) 
 
paclitaxel, medicin til behandling af kræft. 
 
nicorandil, medicin til behandling af hjerte-relaterede smerter i brystkassen 
 
opioider: mens du er i behandling med clopidogrel, bør du fortælle det til lægen, før du får 
ordineret enhver form for behandling med opioider. </li>
</ul>
<p>Du skal holde op med at tage andre lægemidler, der indeholder clopidogrel, mens du tager 
Clopidogrel/Acetylsalicylsyre Zentiva. </p>
<p>Lejlighedsvis anvendelse af acetylsalicylsyre (ikke over 1.000 mg over en periode på 24 timer) burde 
generelt ikke give problemer, men hvis du tager acetylsalicylsyre gennem længere tid under andre 
omstændigheder, skal du diskutere det med lægen eller apotekspersonalet. </p>
<p>Graviditet og amning 
Du må ikke tage Clopidogrel/Acetylsalicylsyre Zentiva under graviditetens tredje trimester. 
Det er bedst ikke at tage dette lægemiddel under graviditens første og andet trimester.  </p>
<p>Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge eller apotekspersonalet til råds, før du tager Clopidogrel/Acetylsalicylsyre Zentiva.<br />
Hvis du bliver gravid, mens du tager Clopidogrel/Acetylsalicylsyre Zentiva, skal du omgående 
kontakte din læge, da det frarådes at tage Clopidogrel/Acetylsalicylsyre Zentiva under graviditet. </p>
<p>Du bør ikke amme, mens du tager Clopidogrel/Acetylsalicylsyre Zentiva.<br />
Hvis du ammer eller planlægger at amme, skal du tale med din læge, før du tager dette lægemiddel.  </p>
<p>Spørg din læge eller apoteket til råds, før du tager nogen form for medicin. </p>
<p>Trafik- og arbejdssikkerhed 
Det er usandsynligt, at Clopidogrel/Acetylsalicylsyre Zentiva vil påvirke din evne til at køre bil eller 
betjene maskiner. </p>
<p>Clopidogrel/Acetylsalicylsyre Zentiva indeholder lactose 
Kontakt lægen, før du tager denne medicin, hvis lægen har fortalt dig, at du ikke tåler visse </p>
<p>sukkerarter. </p>
<p>Clopidogrel/Acetylsalicylsyre Zentiva indeholder hydrogeneret ricinusolie 
Clopidogrel/Acetylsalicylsyre Zentiva indeholder hydrogeneret ricinusolie, der kan forårsage 
mavetilfælde eller diaré.  </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take clopidogrelacetylsalicylic"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take clopidogrelacetylsalicylic"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er du i tvivl, så spørg 
lægen eller apotekspersonalet. </p>
<p>Den anbefalede dosis er 1 tablet Clopidogrel/Acetylsalicylsyre Zentiva dagligt, som indtages gennem 
munden med et glas vand. Clopidogrel/Acetylsalicylsyre Zentiva kan tages i forbindelse med et 
måltid, men det er ikke nødvendigt.  </p>
<p>Du skal tage medicinen på samme tid hver dag. </p>
<p>Ud fra din sygdom vil lægen bestemme, hvor lang tid du skal tage Clopidogrel/Acetylsalicylsyre 
Zentiva. Hvis du har haft et hjerteanfald, skal medicinen udskrives til mindst fire uger. Under alle 
omstændigheder skal du fortsætte med at tage Clopidogrel/Acetylsalicylsyre Zentiva, så længe din 
læge udskriver det til dig. </p>
<p>Hvis du har taget for mange Clopidogrel/Acetylsalicylsyre Zentiva 
Kontakt din læge eller tag på den nærmeste skadestue på grund af den øgede blødningsrisiko. </p>
<p>Hvis du har glemt at tage Clopidogrel/Acetylsalicylsyre Zentiva 
Hvis du glemmer at tage en dosis Clopidogrel/Acetylsalicylsyre Zentiva til sædvanlig tid, men 
kommer i tanke om det i løbet af 12 timer, skal du omgående tage tabletten og dernæst tage den næste 
tablet til sædvanlig tid. </p>
<p>Hvis du glemmer at tage en tablet i over 12 timer, skal du blot tage den næste enkeltdosis til sædvanlig 
tid. Du må ikke tage en dobbeltdosis som erstatning for den glemte tablet. </p>
<p>For pakninger med 14, 28 og 84 stk. tabletter kan du tjekke på hvilken dag, du sidst tog en tablet, ved 
at se på kalenderen trykt på blisterpakningen. </p>
<p>Hvis du holder op med at tage Clopidogrel/Acetylsalicylsyre Zentiva 
Du må ikke stoppe behandlingen, medmindre din læge har bedt dig om det. Kontakt din læge, før 
du stopper eller genoptager din behandling. </p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Kontakt din læge med det samme, hvis du oplever: 
 
feber, tegn på infektion eller ekstrem træthed. Dette kan ske på grund af et sjældent fald i visse 
blodlegemer. 
 
tegn på leverproblemer såsom gulfarvning af huden og/eller øjnene (gulsot), uanset om det sker 
i forbindelse med blødninger, som viser sig under huden som små røde prikker, og/eller 
forvirring (se afsnit 2 ’Advarsler og forsigtighedsregler’). 
 
hævelser i munden eller hudproblemer såsom udslæt og kløe, blærer på huden. Dette kan være 
tegn på en allergisk reaktion. </p>
<p>Den almindeligste bivirkning, der er set med Clopidogrel/Acetylsalicylsyre Zentiva, er blødning. 
Blødning kan forekomme i form af blødninger fra mave eller tarm, blå mærker, hæmatom (usædvanlig 
blødning eller blodudtrædning under huden), næseblod eller blod i urinen. I nogle enkelte tilfælde er 
der indberettet blødning i øjne, i hoved (særligt hos ældre), lunger eller led.  </p>
<p>Hvis du får langvarige blødninger, mens du tager Clopidogrel/Acetylsalicylsyre Zentiva 
Hvis du skærer dig eller kommer til skade, kan det tage lidt længere end normalt, før blødningen 
stopper. Dette skyldes medicinens virkemåde, da den forhindrer blodet i at størkne. Ved mindre sår og 
skader, som hvis du f.eks. skærer dig under barbering, er dette som regel ikke noget problem. Hvis du 
er bekymret over blødningen, skal du omgående kontakte din læge (se afsnit 2 ’Advarsler og 
forsigtighedsregler’). </p>
<p>Øvrige bivirkninger omfatter: 
Almindelige bivirkninger (kan påvirke op til 1 ud af 10 patienter):<br />
Diaré, mavesmerter, fordøjelsesbesvær eller halsbrand. </p>
<p>Ikke almindelige bivirkninger (kan påvirke op til 1 ud af 100 patienter):<br />
Hovedpine, mavesår, opkastninger, kvalme, forstoppelse, luft i maven eller tarmene, udslæt, kløe, 
svimmelhed, prikkende fornemmelse og følelsesløshed. </p>
<p>Sjældne bivirkninger (kan påvirke op til 1 ud af 1.000 patienter):<br />
Svimmelhed (fornemmelse af at snurre rundt), forstørrede bryster hos mænd. </p>
<p>Meget sjældne bivirkninger (kan påvirke op til 1 ud af 10.000 patienter):<br />
Gulsot (gulfarvning af hud og/eller øjne); brændende fornemmelse i maven og/eller spiserøret; 
alvorlige mavesmerter med eller uden rygsmerter; feber, åndedrætsbesvær indimellem i ledsaget af 
hoste; generelle allergiske reaktioner (f.eks. varmefølelse over hele kroppen med pludselig almen 
utilpashed og eventuelt besvimelse); hævelse i munden; blærer på huden; allergiske hudreaktioner; 
ømhed i munden (stomatitis); blodtryksfald; forvirring; hallucinationer; ledsmerter; muskelsmerter; 
smagsforstyrrelser eller mangel på smagssans, betændelse i små kar. </p>
<p>Bivirkninger med ikke kendt hyppighed (kan ikke vurderes ud fra forhåndenværende data):<br />
Perforeret mavesår, ringen for ørerne, nedsat hørelse, pludselige, livstruende allergiske reaktioner eller 
overfølsomhedsreaktioner med bryst- eller mavesmerter, nyresygdom, lavt blodsukker, urinsur gigt 
(en tilstand med smertefulde, hævede led forårsaget af urinsyrekrystaller), forværring af madallergi og 
en særlig form for anæmi (lavt antal røde blodceller) (se afsnit 2 ‘Advarsler og forsigtighedsregler’), 
hævelse. </p>
<p>Derudover kan din læge eventuelt finde ændringer i resultaterne af dine blod- eller urinprøver. </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket. Dette gælder 
også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan 
også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store clopidogrelacetylsalicylic"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store clopidogrelacetylsalicylic"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen efter Exp. Udløbsdatoen er den 
sidste dag i den nævnte måned. </p>
<p>Opbevares ved temperaturer under 25 ºC. </p>
<p>Brug ikke lægemidlet, hvis der er synlige tegn på nedbrydning. </p>
<p>Spørg på apoteket, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke smide 
medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Clopidogrel/Acetylsalicylsyre Zentiva indeholder: </p>
<p>Clopidogrel/Acetylsalicylsyre Zentiva 75 mg/75 mg filmovertrukne tabletter 
Aktive stoffer: clopidogrel og acetylsalicylsyre (ASA). Hver tablet indeholder 75 mg clopidogrel (som 
hydrogensulfat) og 75 mg acetylsalicylsyre. </p>
<p>Øvrige indholdsstoffer:</p>
<ul>
<li>Tabletkernen: mannitol (E421), macrogol 6000, mikrokrystallinsk cellulose, lavsubstitueret 
hydroxypropylcellulose, majsstivelse, hydrogeneret ricinusolie (se afsnit 2 
‘Clopidogrel/Acetylsalicylsyre Zentiva indeholder hydrogeneret ricinusolie’), stearinsyre og 
kolloid vandfri silica. </li>
<li>Tablettens overtræk: lactosemonohydrat (se afsnit 2 ‘Clopidogrel/Acetylsalicylsyre Zentiva 
indeholder lactose’), hypromellose (E464), titandioxid (E171), triacetin (E1518), gul jernoxid 
(E172) </li>
<li>Polérmiddel: carnaubavoks. </li>
</ul>
<p>Clopidogrel/Acetylsalicylsyre Zentiva 75 mg/100 mg filmovertrukne tabletter 
Aktive stoffer: clopidogrel og acetylsalicylsyre (ASA). Hver tablet indeholder 75 mg clopidogrel (som 
hydrogensulfat) og 100 mg acetylsalicylsyre. </p>
<p>Øvrige indholdsstoffer:</p>
<ul>
<li>Tabletkernen: mannitol (E421), macrogol 6000, mikrokrystallinsk cellulose, lavsubstitueret 
hydroxypropylcellulose, hydrogeneret ricinusolie (se afsnit 2 ‘Clopidogrel/Acetylsalicylsyre 
Zentiva indeholder hydrogeneret ricinusolie’), stearinsyre og kolloid vandfri silica. </li>
<li>Tablettens overtræk: lactosemonohydrat (se afsnit 2 ‘Clopidogrel/Acetylsalicylsyre Zentiva 
indeholder lactose’), hypromellose (E464), titandioxid (E171), triacetin (E1518), rød jernoxid 
(E172) </li>
<li>Polérmiddel: carnaubavoks. </li>
</ul>
<p>Udseende og pakningsstørrelser </p>
<p>Clopidogrel/Acetylsalicylsyre Zentiva 75 mg/75 mg filmovertrukne tabletter 
Clopidogrel/Acetylsalicylsyre Zentiva 75 mg/75 mg filmovertrukne tabletter (tabletter) er ovale, let 
bikonvekse, gule og er præget på den ene side med "C75" og på den anden side med "A75".<br />
Clopidogrel/Acetylsalicylsyre Zentiva udleveres i pakninger, der indeholder<br />
- 14, 28, 30 og 84 tabletter i aluminiumblister,<br />
- 30x1, 50x1, 90x1 eller 100x1 tabletter i perforerede enkeltdosisblister i aluminium. </p>
<p>Clopidogrel/Acetylsalicylsyre Zentiva 75 mg/100 mg filmovertrukne tabletter 
Clopidogrel/Acetylsalicylsyre Zentiva 75 mg/100 mg filmovertrukne tabletter (tabletter) er ovale, let 
bikonvekse, lyserøde og er præget på den ene side med "C75" og på den anden side med "A100".<br />
Clopidogrel/Acetylsalicylsyre Zentiva udleveres i pakninger, der indeholder:</p>
<ul>
<li>14, 28 og 84 tabletter i aluminiumblister,  </li>
<li>30x1, 50x1, 90x1 eller 100x1 tabletter i perforerede enkeltdosisblister i aluminium. </li>
</ul>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller </p>
<p>Indehaver af markedsføringstilladelsen:<br />
sanofi-aventis groupe 
54, rue La Boétie 
F-75008 Paris 
Frankrig </p>
<p>Fremstiller: 
Sanofi Winthrop Industrie 
1, rue de la Vierge, Ambarès &amp; Lagrave, F-33565 Carbon Blanc cedex, Frankrig </p>
<p>Hvis du ønsker yderligere oplysninger om Clopidogrel/Acetylsalicylsyre Zentiva, skal du henvende 
dig til den lokale repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
Sanofi Belgium 
Tél/Tel: +32 (0)2 710 54<br />
Lietuva 
UAB «SANOFI-AVENTIS LIETUVA» 
Tel: +370 5 2755 
България 
SANOFI BULGARIA EOOD 
Тел: +359 (0)2 970 53<br />
Luxembourg/Luxemburg 
Sanofi Belgium<br />
Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien) </p>
<p>Česká republika 
sanofi-aventis, s.r.o. 
Tel: +420 233 086<br />
Magyarország 
SANOFI-AVENTIS Zrt. 
Tel.: +36 1 505 0Danmark 
Sanofi A/S 
Tlf: +45 45 16 70<br />
Malta 
Sanofi Malta Ltd. 
Tel: +356 21493 
Deutschland 
Zentiva Pharma GmbH 
Tel: +49 (0)180 20 200<br />
Nederland 
sanofi-aventis Netherlands B.V. 
Tel: +31 20 245 4 
Eesti 
sanofi-aventis Estonia OÜ 
Tel: +372 627 3 
Norge 
sanofi-aventis Norge AS 
Tlf: +47 67 10 71<br />
Ελλάδα 
sanofi-aventis AEBE 
Τηλ: +30 210 900 16<br />
Österreich 
sanofi-aventis GmbH 
Tel: +43 1 80 185 – 0 </p>
<p>España 
sanofi-aventis, S.A. 
Tel: +34 93 485 94<br />
Polska 
sanofi-aventis Sp. z o.o. 
Tel: +48 22 280 00<br />
France 
sanofi-aventis France 
Tél: 0 800 222 Appel depuis l’étranger: +33 1 57 63 23<br />
Portugal 
Sanofi - Produtos Farmacêuticos, Lda 
Tel: +351 21 35 89  </p>
<p>Hrvatska 
sanofi-aventis Croatia d.o.o. 
Tel: +385 1 600 34 România 
Sanofi Romania SRL 
Tel: +40 (0) 21 317 31<br />
Ireland 
sanofi-aventis Ireland Ltd. T/A SANOFI 
Tel: +353 (0) 1 403 56<br />
Slovenija 
sanofi-aventis d.o.o. 
Tel: +386 1 560 48<br />
Ísland 
Vistor hf. 
Sími: +354 535 7 
Slovenská republika 
sanofi-aventis Pharma Slovakia s.r.o. 
Tel: +421 2 33 100<br />
Italia 
Sanofi S.p.A. 
Tel: 800.536<br />
Suomi/Finland 
Sanofi Oy 
Puh/Tel: +358 (0) 201 200<br />
Κύπρος 
sanofi-aventis Cyprus Ltd. 
Τηλ: +357 22 871 
Sverige 
Sanofi AB 
Tel: +46 (0)8 634 50<br />
Latvija 
sanofi-aventis Latvia SIA 
Tel: +371 67 33 24<br />
United Kingdom 
Sanofi 
Tel: +44 (0) 845 372 7 </p>
<p>Denne indlægsseddel blev senest ændret MM/ÅÅÅÅ </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu/ </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-0038e5833697485dc38d33d1305d9883
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for clopidogrelacetylsalicylic Package Leaflet for language en"
Description: "ePI document Bundle for clopidogrelacetylsalicylic Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-0038e5833697485dc38d33d1305d9883"
* entry[0].resource = composition-en-0038e5833697485dc38d33d1305d9883

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp0038e5833697485dc38d33d1305d9883"
* entry[=].resource = mp0038e5833697485dc38d33d1305d9883
                            
                    
Instance: bundlepackageleaflet-da-0038e5833697485dc38d33d1305d9883
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for clopidogrelacetylsalicylic Package Leaflet for language da"
Description: "ePI document Bundle for clopidogrelacetylsalicylic Package Leaflet for language da"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-0038e5833697485dc38d33d1305d9883"
* entry[0].resource = composition-da-0038e5833697485dc38d33d1305d9883

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp0038e5833697485dc38d33d1305d9883"
* entry[=].resource = mp0038e5833697485dc38d33d1305d9883
                            
                    



Instance: mp0038e5833697485dc38d33d1305d9883
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product clopidogrelacetylsalicylic"
Description: "clopidogrelacetylsalicylic"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/75 mg film-coated tablets"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* indication = "Clopidogrel/Acetylsalicylic acid Zentiva is indicated for the secondary prevention of atherothrombotic"


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "clopidogrelacetylsalicylic"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#DK "DK"
    * jurisdiction = urn:iso:std:iso:3166#DK "DK"
    * language = urn:ietf:bcp:47#en  "en"




RuleSet: 0038e5833697485dc38d33d1305d9883ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "clopidogrelacetylsalicylic"

* status = #current
* mode = #working

* title = "List of all ePIs associated with clopidogrelacetylsalicylic"

* subject = Reference(mp4508a59f31e3d5810d220a288641c8f2)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#clopidogrelacetylsalicylic "clopidogrelacetylsalicylic"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-0038e5833697485dc38d33d1305d9883) // clopidogrelacetylsal en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-0038e5833697485dc38d33d1305d9883) // clopidogrelacetylsal da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-0038e5833697485dc38d33d1305d9883
InstanceOf: List

* insert 0038e5833697485dc38d33d1305d9883ListRuleset
    